Each year, prostate cancer accounts for around 25% of all male cancers and 10% of male cancer deaths, with over 107,000 people estimated to have died from the disease in 2018.1,2
Studies have indicated that people with a Black, Asian and minority ethnic (BAME) background have a 30% higher mortality rate than their Caucasian counterparts.3
Nordic and Baltic countries tend to have higher mortality rates compared to southern Europe.4 While the estimated prostate cancer mortality in Italy is 24.5 per 100,000 inhabitants, this rises to 50.9 per 100,000 in Estonia, more than twice that of Italy.4
1
Health and Environmental Alliance (HEAL). Health costs in the European Union: How much is related to EDCS? 2014. Accessible at https://www.env-health.org/IMG/pdf/18062014_final_health_costs_in_the_european_union_how_much_is_realted_to_edcs.pdf (last accessed September 2020)
2
Ferlay, J et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. European Journal of Cancer. 2018; 103:356-387
3
Jones, ALC and Chinegwundoh F. Update on prostate cancer in black men within the UK. Ecancermedicalscience. 2014; 8: 455
4
Hofmarcher, T et al. Comparator Report on Cancer in Europe in 2019. IHE Report 2019:7. Accessible at https://www.efpia.eu/publications/cancer-comparator-report/cancer-types/prostate-cancer/ (last accessed September 2020)
